Global Small Molecule Drug Discovery Market Research Report 2021: Lead Optimization, Lead Identification, Hit Generation and Selection, Target ID/Validation – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Small Molecule Drug Discovery – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Small Molecule Drug Discovery Market to Reach $43.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Small Molecule Drug Discovery estimated at US$30.1 Billion in the year 2020, is projected to reach a revised size of US$43.7 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027.

Oncology, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$18.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Central Nervous System segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $8.9 Billion, While China is Forecast to Grow at 5% CAGR

The Small Molecule Drug Discovery market in the U.S. is estimated at US$8.9 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Cardiovascular Segment to Record 5.4% CAGR

In the global Cardiovascular segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$917.5 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5 Billion by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 46 Featured):

• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• World Current & Future Analysis for Small Molecule Drug Discovery by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
• World Historic Review for Small Molecule Drug Discovery by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
• World 15-Year Perspective for Small Molecule Drug Discovery by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
• World 15-Year Perspective for Oncology by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Central Nervous System by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Cardiovascular by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Anti-Infective by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Immunological by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Other Therapeutic Areas by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Target Id/Validation by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Hit Generation and Selection by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Lead Identification by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027
• World 15-Year Perspective for Lead Optimization by Geographic Region – Percentage Breakdown of Value Sales for Years 2012, 2020 & 2027

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/ijdqu

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900